ARMISTICE CAPITAL, LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 3 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2018$5,723,000
-40.0%
21,760,0000.0%0.43%
-24.1%
Q3 2018$9,531,000
+0.4%
21,760,0000.0%0.57%
-7.7%
Q2 2018$9,494,000
-5.6%
21,760,0000.0%0.62%
-19.4%
Q1 2018$10,053,000
+9.6%
21,760,0000.0%0.77%
-16.0%
Q4 2017$9,175,000
+0.2%
21,760,0000.0%0.92%
-15.2%
Q3 2017$9,161,000
+29.9%
21,760,000
-4.4%
1.08%
+20.0%
Q2 2017$7,053,000
+4.6%
22,760,0000.0%0.90%
-35.5%
Q1 2017$6,745,000
+20.2%
22,760,0000.0%1.39%
+4.9%
Q4 2016$5,612,000
+16.1%
22,760,0000.0%1.33%
-14.4%
Q3 2016$4,834,0000.0%22,760,0000.0%1.55%
-15.7%
Q2 2016$4,834,00022,760,0001.84%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 10,000,000$1,000,0000.64%
ARMISTICE CAPITAL, LLC 21,760,000$5,723,0000.43%
Avoro Capital Advisors LLC 6,000,000$2,545,0000.15%
Bruce & Co., Inc. 2,000,000$250,0000.05%
ZAZOVE ASSOCIATES LLC 2,000,000$300,0000.03%
Perceptive Advisors 1,000,000$642,0000.02%
TENOR CAPITAL MANAGEMENT Co., L.P. 2,000,000$221,0000.02%
Aisling Capital LLC 2,500,000$16,0000.01%
683 Capital Management, LLC 9,000,000$68,0000.00%
Jefferies Group LLC 5,715,000$57,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders